… surfactants is to diminish surface tension in the alveoli at the air–liquid interface and inhibit
its collapse at … current results for SP-D in ALI/ARDS from preclinical and clinical studies. Our …

… of the patients, exogenous surfactant administration, liquid mechanical ventilation and …
alternative therapy for patients with ALI/ARDS. The lungs will be partially filled with the liquid while …

… proteins progressively increase early in ALI/ARDS, they may reflect … we imputed missing
surfactant protein data at day 3 by … Plasma SP-D levels may therefore be useful in future clinical …

… odds ratio of 2.8 for ALI/ARDS patients presenting with sepsis.In … While these results are
disappointing, the surfactant … future therapies aimed at reducing long-term ARDS morbidity. …

… , and surfactant therapy showed more adverse events in the active … their potential benefit
in the treatment of ALI/ARDS. … When pooled analyses included at least five studies, we …

… of combustion atmosphere induced ALI/ARDS which can he … This figure has gained credence
through repeated use in the … use of exogenous surfactant administration was introduced …

… and highlights areas of future perspectives in therapeutics. … The cuboidal type II AECs
secrete a surfactant that is believed … a causal factor for development of ALI/ARDS [51]. However, …

… therapy in the treatment of ALI/ARDS. Considerable progress in the understanding of the
pathogenesis of ALI/ARDS … of different treatment modalities. In addition, ventilator adjunctive …

… , and during this specific period exogenous surfactant treatment may be considered (11). …
Therefore, we decided to use budesonide combined with surfactant treatment to (i) minimize …

… of exogenous surfactant treatment in adults with ALI/ARDS. … analyze groups separately in
the future. Other complex analyses … with ALI/ARDS during the first 24 hours after administration …